Novel vaccine delivery includes formulations, technologies, methods, and systems to transfer an active pharmaceutical ingredient in the body, as desired, in order to safely accomplish its therapeutic effect.
This report contains market size and forecasts of Novel Vaccine Delivery Systems in Global, including the following market information:
Global Novel Vaccine Delivery Systems Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Novel Vaccine Delivery Systems market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Intramuscular Delivery Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Novel Vaccine Delivery Systems include Altaris Capital Partners, Kindeva Drug Delivery, Becton, Dickinson,, Carl Zeiss Foundation, Gerresheimer AG, Corium International, Inovio Pharmaceuticals and Bioject Medical Technologies, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Novel Vaccine Delivery Systems companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Novel Vaccine Delivery Systems Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Novel Vaccine Delivery Systems Market Segment Percentages, by Type, 2021 (%)
Intramuscular Delivery
Intramuscular Delivery
Others
Global Novel Vaccine Delivery Systems Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Novel Vaccine Delivery Systems Market Segment Percentages, by Application, 2021 (%)
Hospitals & Clinics
Research Institutes
Others
Global Novel Vaccine Delivery Systems Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Novel Vaccine Delivery Systems Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Novel Vaccine Delivery Systems revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Novel Vaccine Delivery Systems revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Altaris Capital Partners
Kindeva Drug Delivery
Becton
Dickinson,
Carl Zeiss Foundation
Gerresheimer AG
Corium International
Inovio Pharmaceuticals
Bioject Medical Technologies
PharmaJet
Retractable Technologies
Terumo Corporation
VAXXAS